These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23812939)

  • 21. The efficacy of tissue Doppler imaging in predicting myocardial iron load in patients with beta-thalassemia major: correlation with T2* cardiovascular magnetic resonance.
    Aypar E; Alehan D; Hazirolan T; Gümrük F
    Int J Cardiovasc Imaging; 2010 Apr; 26(4):413-21. PubMed ID: 20127175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients.
    Meloni A; Positano V; Pistoia L; Righi R; Missere M; Grassedonio E; Schicchi N; Vallone A; Gamberini MR; Cuccia L; Lisi R; Cecinati V; Spasiano A; Cademartiri F
    Int J Cardiovasc Imaging; 2023 May; 39(5):991-999. PubMed ID: 36637709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
    Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
    Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.
    Pennell DJ; Udelson JE; Arai AE; Bozkurt B; Cohen AR; Galanello R; Hoffman TM; Kiernan MS; Lerakis S; Piga A; Porter JB; Walker JM; Wood J;
    Circulation; 2013 Jul; 128(3):281-308. PubMed ID: 23775258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of global strain values of myocardium in beta-thalassemia major patients with iron load using specific feature tracking in cardiac magnetic resonance imaging.
    Rezaeian N; Mohtasham MA; Khaleel AJ; Parnianfard N; Kasani K; Golshan R
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1343-1349. PubMed ID: 32346846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.
    Pennell DJ; Porter JB; Cappellini MD; El-Beshlawy A; Chan LL; Aydinok Y; Elalfy MS; Sutcharitchan P; Li CK; Ibrahim H; Viprakasit V; Kattamis A; Smith G; Habr D; Domokos G; Roubert B; Taher A
    Blood; 2010 Mar; 115(12):2364-71. PubMed ID: 19996412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of left atrial contractile function: a herald of iron overload in patients with beta thalassemia major.
    Shabanian R; Heidari-Bateni G; Kocharian A; Mashayekhi M; Hosseinzadeh S; Kiani A; Izadyar M; Koochakzadeh L
    Pediatr Cardiol; 2010 Jul; 31(5):680-8. PubMed ID: 20383704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of myocardial iron overload by two-dimensional speckle tracking in patients with beta-thalassaemia major: a combined echocardiographic and T2* segmental CMR study.
    Pizzino F; Meloni A; Terrizzi A; Casini T; Spasiano A; Cosmi C; Allò M; Zito C; Carerj S; Aquaro GD; Di Bella G; Pepe A
    Int J Cardiovasc Imaging; 2018 Feb; 34(2):263-271. PubMed ID: 28770456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T2* imaging of the heart: methods, applications, and outcomes.
    Baksi AJ; Pennell DJ
    Top Magn Reson Imaging; 2014 Feb; 23(1):13-20. PubMed ID: 24509620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of myocardial T2* to right ventricular function in thalassaemia major.
    Alpendurada F; Carpenter JP; Deac M; Kirk P; Walker JM; Porter JB; Banya W; He T; Smith GC; Pennell DJ
    Eur Heart J; 2010 Jul; 31(13):1648-54. PubMed ID: 20413399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How early can myocardial iron overload occur in beta thalassemia major?
    Yang G; Liu R; Peng P; Long L; Zhang X; Yang W; Tan S; Pan H; Long X; He T; Anderson L; Lai Y
    PLoS One; 2014; 9(1):e85379. PubMed ID: 24465548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial iron overload in thalassaemia major. How early to check?
    Borgna-Pignatti C; Meloni A; Guerrini G; Gulino L; Filosa A; Ruffo GB; Casini T; Chiodi E; Lombardi M; Pepe A
    Br J Haematol; 2014 Feb; 164(4):579-85. PubMed ID: 24460526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.
    Anderson LJ; Holden S; Davis B; Prescott E; Charrier CC; Bunce NH; Firmin DN; Wonke B; Porter J; Walker JM; Pennell DJ
    Eur Heart J; 2001 Dec; 22(23):2171-9. PubMed ID: 11913479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between left ventricular strain and cardiac iron load in beta-thalassaemia major: a cardiac magnetic resonance study.
    Alis D; Asmakutlu O; Topel C; Sahin AA; Karaarslan E
    Acta Cardiol; 2022 Feb; 77(1):71-80. PubMed ID: 33685353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach.
    Pepe A; Meloni A; Rossi G; Midiri M; Missere M; Valeri G; Sorrentino F; D'Ascola DG; Spasiano A; Filosa A; Cuccia L; Dello Iacono N; Forni G; Caruso V; Maggio A; Pitrolo L; Peluso A; De Marchi D; Positano V; Wood JC
    Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):299-309. PubMed ID: 28200076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients.
    Cassinerio E; Roghi A; Orofino N; Pedrotti P; Zanaboni L; Poggiali E; Giuditta M; Consonni D; Cappellini MD
    Ann Hematol; 2015 Jun; 94(6):939-45. PubMed ID: 25563596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging.
    Nagao M; Matsuo Y; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Abe K; Mukai Y; Higo T; Yabuuchi H; Takemura A; Yoshiura T; Sunagawa K; Honda H
    Am J Cardiol; 2014 Mar; 113(6):1024-30. PubMed ID: 24461766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac complications in thalassemia major.
    Auger D; Pennell DJ
    Ann N Y Acad Sci; 2016 Mar; 1368(1):56-64. PubMed ID: 26963698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of left ventricular diastolic dysfunction by cardiac magnetic resonance imaging in thalassemia major patients with normal left ventricular systolic function.
    Chinprateep B; Ratanasit N; Kaolawanich Y; Karaketklang K; Saiviroonporn P; Viprakasit V; Krittayaphong R
    BMC Cardiovasc Disord; 2019 Nov; 19(1):245. PubMed ID: 31694552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.